Related Experiment Video
Updated: Feb 18, 2026

Inducible and Reversible Dominant-negative DN Protein Inhibition
Published on: January 7, 2019
TET1 inhibits cell proliferation by inducing RASSF5 expression
Bo-Tai Li1, Chao Yu1, Ying Xu2
1Life Sciences Institute, Zhejiang University, Hangzhou 301158, China.
Abstract:
Tet methylcytosine dioxygenases (TETs) catalyze the oxidative reactions of 5-methylcytosine to 5-hydroxymethylcytosine (5hmC). However, TET1 roles in ovarian cancer cell growth are unknown. Here, we show that ectopic expression of TET1 increased 5hmC levels, and inhibited proliferation and colony formation in ovarian cancer cell lines. Furthermore, in vitro and in vivo functional studies demonstrated that TET1 overexpression is necessary for the suppression of ovarian cancer growth, whereas depletion of TET1 expression had the opposite effect. Furthermore, the results of RNA-seq and qRT-PCR analyses identified a tumor suppressor, Ras association domain family member 5 (RASSF5), as the key downstream target of TET1. TET1 promotes RASSF5 expression by demethylating a CpG site within RASSF5 promoter. Up-regulated RASSF5 expression leads to the suppression of ovarian cancer cells growth. Additionally, we demonstrated that inhibition of CUL4-DDB1 ubiquitin ligase complex decrease 5hmC levels in ovarian cancer cells. These results provide new insights into the understanding of how ovarian cancers develop and grow, and identify TET1 as a key player in this process.
Insights
Tet methylcytosine dioxygenase 1 (TET1) suppresses ovarian cancer growth by increasing 5-hydroxymethylcytosine (5hmC) levels and upregulating the tumor suppressor Ras association domain family member 5 (RASSF5). TET1 acts as a key player in regulating ovarian cancer progression.
Area of Science:
- Epigenetics
- Cancer Biology
- Molecular Oncology
Background:
- Tet methylcytosine dioxygenases (TETs) oxidize 5-methylcytosine to 5-hydroxymethylcytosine (5hmC).
- The specific role of TET1 in ovarian cancer cell proliferation and growth remains largely unexplored.
Purpose of the Study:
- To investigate the function of TET1 in ovarian cancer.
- To identify downstream targets and mechanisms through which TET1 influences ovarian cancer progression.
Main Methods:
- Ovarian cancer cell lines were utilized for ectopic expression and depletion studies of TET1.
- In vitro and in vivo functional assays assessed proliferation and colony formation.
- RNA sequencing (RNA-seq) and quantitative reverse transcription PCR (qRT-PCR) identified downstream targets.
- DNA methylation analysis of the RASSF5 promoter was performed.
Main Results:
- Ectopic TET1 expression elevated 5hmC levels, inhibited ovarian cancer cell proliferation and colony formation.
- TET1 overexpression suppressed tumor growth in vitro and in vivo, while TET1 depletion promoted it.
- Ras association domain family member 5 (RASSF5) was identified as a key downstream target, with TET1 promoting its expression via demethylation of its promoter.
- Inhibition of the CUL4-DDB1 ubiquitin ligase complex reduced 5hmC levels in ovarian cancer cells.
Conclusions:
- TET1 functions as a tumor suppressor in ovarian cancer by increasing 5hmC and upregulating RASSF5 expression.
- TET1-mediated RASSF5 upregulation inhibits ovarian cancer cell growth.
- These findings elucidate a novel mechanism in ovarian cancer development and identify TET1 as a potential therapeutic target.
Related Concept Videos
The Ras Gene
Ras is a...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Abnormal Proliferation
Negative Regulator Molecules
PI3K/mTOR/AKT Signaling Pathway
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...

